focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Marketing approval of nicotine gum in Europe

20 Nov 2013 07:00

RNS Number : 4427T
Revolymer PLC
20 November 2013
 



20th November, 2013

Revolymer plc

Revolymer files for marketing approval of its nicotine gum in Europe

Revolymer plc ("Revolymer" or the "Company"), the British polymer technology company, is pleased to announce that, on the 19th November 2013, its wholly-owned UK operating subsidiary Revolymer (U.K.) Limited filed for marketing authorisation in Europe of its proprietary nicotine gum products by submitting an application under Directive 2001/83/EC to the Medicines and Healthcare products Regulatory Agency (MHRA).

If approved, such authorisation will permit the marketing of Revolymer's 2mg and 4mg strength nicotine gum in the UK, Ireland, Poland and Spain. These countries are expected to be the first in Europe where Revolymer's nicotine gum products will be sold. Revolymer has already established a supply and distribution agreement for its nicotine gum in Poland, and aims to conclude commercialisation deals in the UK, Ireland and Spain in due course. The Company also plans to apply for marketing authorisations for additional countries in Europe as it establishes appropriate commercial pathways.

Roger Pettman, Chief Executive of Revolymer said: "I am pleased that our strategy to commercialise our nicotine gum products in Europe is progressing, as demonstrated by the achievement of this latest milestone. We believe that not only is our product bioequivalent to the existing reference product in Europe, but that it has additional benefits that consumers will value, namely a more confectionery-like chew."

The establishment of further nicotine gum commercialisation deals in Europe and the filing for regulatory approval of its nicotine gum in the US are expected to be the subject of future announcements by the Company.

 

Ends

 

For further information please contact:

 

Revolymer plc

+44 (0) 1244 283 500

Roger Pettman

Rob Cridland

 

 

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

 

Citigate Dewe Rogerson

+44 (0)20 7282 2945

David Dible / Ginny Pulbrook/Malcolm Robertson

 

 

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the fast moving consumer goods (FMCG) and other industrial markets. Revolymer aims to generate significant and growing high quality revenue streams by licensing its unique technologies to manufacturers and marketers within these markets. Potential applications for the business's technologies are in the household products, personal care and coatings & adhesives product areas (together "Consumer Specialties") and in medicated chewing gum (including nicotine gum) and confectionery chewing gum (together "Gum").

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMMMMKLDGFZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.